載入...
AZD1208, a potent and selective pan-Pim kinase inhibitor, demonstrates efficacy in preclinical models of acute myeloid leukemia
Upregulation of Pim kinases is observed in several types of leukemias and lymphomas. Pim-1, -2, and -3 promote cell proliferation and survival downstream of cytokine and growth factor signaling pathways. AZD1208 is a potent, highly selective, and orally available Pim kinase inhibitor that effectivel...
Na minha lista:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society of Hematology
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3916880/ https://ncbi.nlm.nih.gov/pubmed/24363397 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2013-04-495366 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|